Status: Recruiting
A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT)
The EUROLIGHT study is being conducted to collect real life data for the safety and effectiveness of PBM in dry AMD, in routine clinical practice both retrospectively and prospectively.
Participants needed: 500
Trial details
Biological sex: AllType: ObservationalSponsor: LumiThera, Inc.Updated: Apr 8, 2024Locations: 1Duration: 3 Years
Eligibility criteria
Diagnosis or confirmation of diagnosis of dry AMD disease by Investigator [+2]
Signs of active, inactive or history of exudative macular neovascularization (MN... [+4]